| Treatment |
Blood parameters |
Biochemical parameters |
| Hb |
RBC |
WBC |
SGOT |
SGPT |
| DC |
9.4 ±0.4 |
4.6 ±0.3 |
13.8 ±1.0 |
293.9 ±11.8 |
182.8 ±14.0 |
| STD (P) |
12.3 ± 0.2* |
6.4 ± 0.1** |
14.6 ± 2.0 |
227 ± 29.9* |
118.8 ± 10.6** |
| SV1 (P)
(1 μg/200gm) |
8.9 ±0.8 |
5.2 ± 0.1 |
2.8 ± 0.3** |
228.3 ± 6.1* |
97.97 ± 6.8** |
| SV2 (P)
(2 μg/200 gm) |
7.3 ±0.3 |
3.9 ± 0.3 |
2.6 ± 0.1** |
216.45 ±9.9** |
81.32 ± 7.0** |
| STD (T) |
11.8 ± 0.4* |
5.8 ± 0.1* |
9.6 ± 1.4 |
219.11 ± 21.2* |
78.25 ±8.7** |
| SV1 (T)
(1 μg/200 gm) |
11.85 ± 0.2* |
6 ±0.1* |
6.11 ±0.3** |
228.01 ± 6.5* |
87.75 ±4.5** |
| SV2 (T)
(2 μg/200 gm) |
12.13 ± 1.0* |
6.43 ± 0.6** |
6.15 ± 0.1** |
230.76 ± 8.6* |
99.35 ± 3.0** |
Values are expressed in mean ±SEM (n=6); *p<0.05, **p<0.01 vs. Disease control group, Data analysed by One-way ANOVA test followed by Dunnet’s multiple test for
comparison. Treatment of various group are as follows, DC: Disease Control, STD: Indomethacin, SV: Scorpion Venom, P: Preventive treatment, T: Therapeutic treatment. |
